Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
10 2020
Historique:
received: 01 05 2020
revised: 14 06 2020
accepted: 16 06 2020
pubmed: 4 7 2020
medline: 4 2 2022
entrez: 4 7 2020
Statut: ppublish

Résumé

To assess the relevance of the endoscopic evaluation in clinically suspected cases of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC), using ESSIC criteria, established in 2008 by the European Society for the Study of Interstitial Cystitis (ESSIC). We included all patients who underwent endoscopic evaluation between January 01, 2015 and October 31, 2019 for clinical suspicion of BPS/IC. Collected data included demographic and baseline clinical features, endoscopic appearance (prior and after hydrodistension), and bladder wall biopsy results, both defined according to ESSIC criteria. Data were cross tabulated to define ESSIC phenotypes, while subgroups and multivariate analyses were carried out to assess the influence of clinical variables on ESSIC phenotypes. Fifty-two subjects were included, mainly women (92%). Median age at evaluation was 45 (32.9-58.2) years. At hydrodistension, 21 patients (42%) had positive and 29 (58%) had negative findings. Grade 2-3 glomerulations were found in 18 patients, while Hunner lesions were reported only in 1 patient. Positive results at biopsy were found in 24 pts (51.1%), while negative in 23 (48.9%). Overall, the positive and negative concordance between hydrodistension and biopsy results was 78%. No significant differences in ESSIC subtypes were found after stratification based on clinical features and at multivariate analysis. Retrospective design is the main limitation. Cystoscopy with hydrodistension and biopsy do have a role in the diagnostic pathway of BPS/IC. However, results should be considered in the clinical context of the individual patient.

Identifiants

pubmed: 32619597
pii: S0090-4295(20)30787-1
doi: 10.1016/j.urology.2020.06.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-110

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Alessandro Morlacco (A)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. Electronic address: alessandro.morlacco@unipd.it.

Mariangela Mancini (M)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Matteo Soligo (M)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Fabio Zattoni (F)

Urology Clinic, University of Udine and University Hospital "Santa Maria della Misericordia", Udine, Italy.

Arturo Calpista (A)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Giuseppe Vizzielli (G)

Division of Gynecologic Oncology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Rosario Patti (R)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Francesco Gerardo Mandato (FG)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Andrea Celeste Barneschi (AC)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Filiberto Zattoni (F)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Massimo Iafrate (M)

Urology Clinic, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.

Fabrizio Dal Moro (F)

Urology Clinic, University of Udine and University Hospital "Santa Maria della Misericordia", Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH